Date ▲ Holder Code Drug Date from Subject 31.3.2023 Teva B.V. (TEV-NL-4) 52119 Olfen 140 mg (emp med 5x140 mg (vre.papier/PE/Al/kopol.etylénmetakryl. kys.)) 11.4.2022 O 31.3.2023 Krewel Meuselbach GmbH (KRE) 25590 Regulax (cub por 18x0,71 g/0,30 g (fólia Al)) 31.3.2023 Z 31.3.2023 Krewel Meuselbach GmbH (KRE) 25584 Regulax (cub por 6x0,71 g/0,30 g (fólia Al)) 31.3.2023 Z 31.3.2023 MEDOCHEMIE Ltd. (MOE) 37099 ARKETIS 20 mg (tbl 30x20 mg (blis.PVC/Al)) 1.4.2023 R 31.3.2023 MEDOCHEMIE Ltd. (MOE) 41152 MEDOCLAV FORTE 312,5 mg (plu por 1x100 ml (fľ.skl.jantárová)) 1.4.2023 O 31.3.2023 MEDOCHEMIE Ltd. (MOE) 65111 MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.)) 1.4.2023 O 31.3.2023 CSL Behring GmbH (CSL) 50936 Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml (liek.inj.skl.)) 30.3.2023 R 31.3.2023 CSL Behring GmbH (CSL) 80027 Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x25 ml (liek.inj.skl.)) 30.3.2023 R 30.3.2023 Chiesi Pharmaceuticals GmbH (CHS-AT) 84575 Otobacid N (int ots 1x5 ml (liek.skl.)) 31.3.2023 O 30.3.2023 Immedica Pharma AB (IMD-SE-1) 27289 BETOPTIC S (int opu 1x5 ml (fľ.PE)) 30.3.2023 O 30.3.2023 Viatris Healthcare Limited (VIM-1) 1139B KLACID 250 mg/5 ml (gru por 1x100 ml (fľ.HDPE+dvojdielna striekačka)) 31.3.2023 R 30.3.2023 Egis Pharmaceuticals PLC (EGI) 4484D Assubex 20 mg (tbl flm 98x20 mg (blis.Al/PVC/PE/PVDC)) 3.4.2023 R 30.3.2023 Nordic Group B.V. (NRC-2) 07499 Teysuno 15 mg/4,35 mg/11,8 mg tvrdé kapsuly (cps dur 126x15 mg/4,35 mg/11,8 mg (blis.PCTFE/PVC/Al)) 31.3.2023 Z 30.3.2023 Nordic Group B.V. (NRC-2) 07501 Teysuno 20 mg/5,8 mg/15,8 mg tvrdé kapsuly (cps dur 84x20 mg/5,8 mg/15,8 mg (blis.PCTFE/PVC/Al)) 31.3.2023 Z 29.3.2023 Berlin-Chemie AG (BCE) 08137 MIG Junior 2% (sus por 1x100 ml (fľ.PET)) 30.3.2023 R
